Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Document Details

Form
Filing Date
May 22, 2026
Document Date
May 21, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
Romano Steven J.